2607 — Shanghai Pharmaceuticals Holding Co Share Price
Last trade - 00:00- HK$39.55bn
- HK$77.43bn
- CNY260.30bn
- 53
- 90
- 36
- 67
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 6.31 | ||
| PEG Ratio (f) | 0.26 | ||
| EPS Growth (f) | 31.97% | ||
| Dividend Yield (f) | 5.86% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.53 | ||
| Price to Tang. Book | 0.72 | ||
| Price to Free Cashflow | 16.15 | ||
| Price to Sales | 0.14 | ||
| EV to EBITDA | 6.55 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.54% | ||
| Return on Equity | 5.56% | ||
| Operating Margin | 2.94% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 186,565.8 | 191,909.16 | 215,824.26 | 231,981.3 | 260,295.09 | 291,698.74 | 321,886.75 | 10.35% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +18.53 | +4.25 | -12.28 | -10.96 | -21.16 | +43.9 | +11.16 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.
Directors
- Jun Zhou CHM (52)
- Min Zuo PRE (59)
- Dawei Ge VCH (58)
- Bo Shen CFO (48)
- Yongzhong Li VPR (51)
- Jinzhu Chen VPR (35)
- Haoliang Gu VPR (59)
- Jianyi Mao VPR (52)
- Yaohua Zhang VPR (47)
- Yong Zhao VPR (49)
- Shui Bing Leung SEC
- An Li NED (59)
- Jiangnan Cai NID (63)
- Chaoyang Gu NID (55)
- Liang Hong NID (45)
- Wenxun Huo NID (64)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 18th, 1994
- Public Since
- March 24th, 1994
- No. of Shareholders
- 84,761
- No. of Employees
- 48,164
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 3,703,301,054
- Address
- Shanghai Pharmaceutical Mansion, SHANGHAI, 200020
- Web
- https://www.sphchina.com/index/
- Phone
- +86 2163730908
- Contact
- Tao Zhong
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for 2607
Similar to 2607
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:19 UTC, shares in Shanghai Pharmaceuticals Holding Co are trading at HK$10.68. This share price information is delayed by 15 minutes.
Shares in Shanghai Pharmaceuticals Holding Co last closed at HK$10.68 and the price had moved by -31.19% over the past 365 days. In terms of relative price strength the Shanghai Pharmaceuticals Holding Co share price has underperformed the FTSE Developed Asia Pacific Index by -30.71% over the past year.
The overall consensus recommendation for Shanghai Pharmaceuticals Holding Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Shanghai Pharmaceuticals Holding Co dividend yield is 4.16% based on the trailing twelve month period.
Last year, Shanghai Pharmaceuticals Holding Co paid a total dividend of CNY0.41, and it currently has a trailing dividend yield of 4.16%. We do not have any data on when Shanghai Pharmaceuticals Holding Co is to next pay dividends.
We do not have data on when Shanghai Pharmaceuticals Holding Co is to next pay dividends. The historic dividend yield on Shanghai Pharmaceuticals Holding Co shares is currently 4.16%.
To buy shares in Shanghai Pharmaceuticals Holding Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$10.68, shares in Shanghai Pharmaceuticals Holding Co had a market capitalisation of HK$39.55bn.
Here are the trading details for Shanghai Pharmaceuticals Holding Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2607
Based on an overall assessment of its quality, value and momentum Shanghai Pharmaceuticals Holding Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Shanghai Pharmaceuticals Holding Co is HK$15.80. That is 47.95% above the last closing price of HK$10.68.
Analysts covering Shanghai Pharmaceuticals Holding Co currently have a consensus Earnings Per Share (EPS) forecast of CNY1.52 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shanghai Pharmaceuticals Holding Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -17.79%.
As of the last closing price of HK$10.68, shares in Shanghai Pharmaceuticals Holding Co were trading -12.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Shanghai Pharmaceuticals Holding Co PE ratio based on its reported earnings over the past 12 months is 6.31. The shares last closed at HK$10.68.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Shanghai Pharmaceuticals Holding Co's management team is headed by:
- Jun Zhou - CHM
- Min Zuo - PRE
- Dawei Ge - VCH
- Bo Shen - CFO
- Yongzhong Li - VPR
- Jinzhu Chen - VPR
- Haoliang Gu - VPR
- Jianyi Mao - VPR
- Yaohua Zhang - VPR
- Yong Zhao - VPR
- Shui Bing Leung - SEC
- An Li - NED
- Jiangnan Cai - NID
- Chaoyang Gu - NID
- Liang Hong - NID
- Wenxun Huo - NID